Differential PSME2 expression in various immunological cancer subtypes was further assessed with TISIDB, revealing a significant relationship between PSME2 levels and immune subtypes for 23 cancer types (Figure 5B, Figure S9B). This evidence concerns the gene PSME2 and cancer.